Moexipril recalls

The FDA has published 2 recalls involving Moexipril since 2012. The latest was reported on 17 Jan 2018. Most were for potency & assay. Teva Pharmaceuticals USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 17 Jan 2018

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why moexipril is recalled

Potency & Assay2100%

Companies

Teva Pharmaceuticals USA150%
Paddock Laboratories150%

By year

2018150%
2012150%

All moexipril recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
17 Jan 2018Drug	CLASS II	Moexipril Hydrochloride and Hydrocholorothiazide Tablets recalled	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
17 Oct 2012Drug	CLASS II	Moexipril HCl Tablets 7.5mg, 100 tabs recalled by Paddock Laboratories	Paddock Laboratories	Potency & Assay	Nationwide

Should you stop taking Moexipril?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.